-
Patient info
-
»
Active substances
Active substances
-
(1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido) butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, ritonavir
-
5-aminolevulinic acid hydrochloride
-
6-mercaptopurine monohydrate
-
A/Cambodia/e0826360/2020 (H3N2)-like strain (A/Tasmania/503/2020, wild type)
-
A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2)
-
A Turkey 14/98 ≥ 6 PD50*
-
A/Victoria/2570/2019 (H1N1)pdm09 like strain (A/Victoria/1/2020, MEDI 340505) A/Cambodia/e0826360/2020 (H3N2) - like strain (A/Tasmania/503/2020, MEDI 339018) B/Washington/02/2019 like strain (B/Washington/02/2019, MEDI 323797) B/Phuket/3073/2013 like
-
A/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/2570/2019 IVR‐215) A/Cambodia/e0826360/2020 (H3N2) - like strain (A/Cambodia/e0826360/2020 IVR‐224) B/Washington/02/2019 – like strain (B/Victoria/705/2018 BVR‐11) B/Phuket/3073/2013 – like strain
-
A/Wisconsin/588/2019 (H1N1)pdm09-like strain (A/Washington/19/2020, wild type)
-
A22 Iraq ≥ 6 PD50*
-
A24 Cruzeiro ≥ 6 PD50*
-
abacavir
-
abacavir (as sulfate), lamivudine, zidovudine
-
abacavir, lamivudine
-
Abatacept
-
abemaciclib
-
abiraterone acetate
-
Abrocitinib
-
Acalabrutinib
-
acetylsalicylic acid, clopidogrel hydrogen sulfate